Tradeweb's strong quarterly results indicate robust performance in key asset classes, which is positive for revenue. The decline in interest rates is favorable for their derivatives business, suggesting potential for increased profitability. Additionally, the acquisition of ICD is likely to enhance revenue through cross-selling, further supporting positive stock movement.